George Gauthier - 18 Apr 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: Chief Commercial Officer
Signature: /s/ Fred Schwarzer, by power of attorney
Issuer symbol: IGMS
Transactions as of: 18 Apr 2023
Transactions value $: $0
Form type: 4
Filing time: 20 Apr 2023, 20:52:50 UTC
Previous filing: 06 Apr 2023
Next filing: 25 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Award	$0	+8.33K	+24.6%	$0.00	42.2K	18 Apr 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of a portion of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.

Content

These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of a portion of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.